Niki BioSolutions, Inc. (NIKI) stock
NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
$1.60+0.10 (+6.67%)
Close on Nov 18, 2026Market cap $13.03MP/E –Yield –
Niki BioSolutions total assets
Total assets on the balance sheet at the end of each period.
Niki BioSolutions's total assets was $18.69M at Dec 31, 2025. For fiscal 2025 it was $18.69M, up 15.9% from the year before. The highest annual figure on record is $45.07M in fiscal 2018.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.69M | +15.9% |
| FY2024 | Dec 31, 2024 | $16.13M | -21.9% |
| FY2023 | Dec 31, 2023 | $20.64M | -1.1% |
| FY2022 | Dec 31, 2022 | $20.87M | -4.7% |
| FY2021 | Dec 31, 2021 | $21.91M | -50.5% |
| FY2020 | Dec 31, 2020 | $44.23M | +84.6% |
| FY2019 | Dec 31, 2019 | $23.95M | -46.9% |
| FY2018 | Dec 31, 2018 | $45.07M | +42.8% |
| FY2017 | Dec 31, 2017 | $31.56M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $18.69M | +5.6% |
| Q3 FY2025 | Sep 30, 2025 | $17.58M | -14.8% |
| Q2 FY2025 | Jun 30, 2025 | $18.10M | +25.6% |
| Q4 FY2024 | Dec 31, 2024 | $16.13M | -22.7% |
| Q2 FY2024 | Jun 30, 2024 | $17.70M | -26.3% |
| Q4 FY2023 | Dec 31, 2023 | $20.64M | -5.8% |
| Q2 FY2023 | Jun 30, 2023 | $14.41M | -54.6% |
| Q4 FY2022 | Dec 31, 2022 | $20.87M | -52.8% |
| Q2 FY2022 | Jun 30, 2022 | $24.02M | +3.0% |
| Q4 FY2021 | Dec 31, 2021 | $21.91M | -8.5% |
| Q2 FY2021 | Jun 30, 2021 | $31.71M | -29.6% |
| Q4 FY2020 | Dec 31, 2020 | $44.23M | +40.2% |
| Q2 FY2020 | Jun 30, 2020 | $23.31M | – |
| Q4 FY2019 | Dec 31, 2019 | $23.95M | – |
| Q4 FY2018 | Dec 31, 2018 | $45.07M | – |
| Q4 FY2017 | Dec 31, 2017 | $31.56M | – |
See a number that looks wrong?